We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$824M
AUM Growth
-$51.7M
Cap. Flow
-$31.3M
Cap. Flow %
-3.8%
Top 10 Hldgs %
74.72%
Holding
32
New
1
Increased
8
Reduced
14
Closed
2

Top Buys

Rank Stock Value
1
AXDX
Accelerate Diagnostics
AXDX
+$13.4M
2
BLUE
bluebird bio
BLUE
+$4.43M
3
TTHI
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
+$3.27M
4
ARAY icon
Accuray
ARAY
+$3.26M
5
PACB icon
Pacific Biosciences
PACB
+$2.14M

Top Sells

Rank Stock Value
1
ECYT
Endocyte, Inc. Common Stock
ECYT
+$16M
2
THC icon
Tenet Healthcare
THC
+$10.7M
3
THOR
THORATEC CORPORATION
THOR
+$9.66M
4
QDEL icon
QuidelOrtho
QDEL
+$7.85M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$3.92M

Sector Composition

Rank Sector Weight
1 Healthcare 76.93%
2 Consumer Staples 0.18%
3 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$29.8B
$2.44M 0.3%
7,723
-3,807
-33% -$1.15M
YTEN
27
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$1.44M 0.18%
29
– –
TNXP icon
28
Tonix Pharmaceuticals
TNXP
$170M
– –
0
– –
ONCT
29
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$366K 0.04%
189
-167
-47% -$330K
LTS
30
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$352K 0.04%
111,789
-55,060
-33% -$157K
AGIO icon
31
Agios Pharmaceuticals
AGIO
$1.82B
– –
-100,000
Closed -$3.92M
ECYT
32
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-670,000
Closed -$16M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2014 Portfolio in Review

As of Q2 2014, Oracle Investment Management held 32 positions worth $824M, down 5.9% from $876M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Oracle Investment Management withdrew a net $31.3M in Q2 2014, closing 2 positions and reducing 14 holdings. Its most notable exit was Endocyte, Inc. Common Stock, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 73% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Oracle Investment Management opened a new position in bluebird bio worth $6.9M.

  • Oracle Investment Management's largest Q2 2014 buy was bluebird bio: 13,814 shares worth $6.9M.
  • Oracle Investment Management added most to Accelerate Diagnostics in Q2 2014, an estimated $13.4M increase.
  • Oracle Investment Management's biggest Q2 2014 reduction was Tenet Healthcare, cutting an estimated $10.7M.
  • Oracle Investment Management fully exited Endocyte, Inc. Common Stock in Q2 2014, selling an estimated $16M.
  • Oracle Investment Management's ten largest holdings make up 75% of its $824M portfolio in Q2 2014.
  • Oracle Investment Management opened 1 new position and closed 2 in Q2 2014.
  • Oracle Investment Management's portfolio value fell 5.9% quarter-over-quarter to $824M.

Based on Oracle Investment Management's 13F filing for Q2 2014, filed 14 Aug 2014.